Sun Pharma Advanced Research Company
Sun Pharma Advanced Research Company Performance
Day Range
- Low 222
- High 231.8
52 Week Range
- Low 162.1
- High 265.85
- Open Price223
- Previous Close222.65
- Volume1201839
Start SIP in Sun Pharma Advanced Research Company
Start SIPSun Pharma Advanced Research Company Investment Rating
-
Master Rating:
-
Sun Pharma Advd.Resh. has an operating revenue of Rs. 234.27 Cr. on a trailing 12-month basis. An annual revenue growth of 73% is outstanding, Pre-tax margin of -93% needs improvement, ROE of -43% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 7% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -10% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 31 which is a POOR score indicating inconsistency in earnings, a RS Rating of 41 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 113 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 24 | 48 | 131 | 32 | 28 | 25 |
Operating Expenses Qtr Cr | 126 | 137 | 115 | 94 | 107 | 92 |
Operating Profit Qtr Cr | -102 | -90 | 16 | -63 | -78 | -67 |
Depreciation Qtr Cr | 3 | 3 | 3 | 3 | 3 | 3 |
Interest Qtr Cr | 0 | 0 | 3 | 3 | 2 | 2 |
Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Net Profit Qtr Cr | -95 | -82 | 10 | -68 | -82 | -71 |
Sun Pharma Advanced Research Company Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 5
- Bearish Moving Average
- ___
- 11
- 20 Day
- ₹237.01
- 50 Day
- ₹231.93
- 100 Day
- ₹222.48
- 200 Day
- ₹217.73
- 20 Day
- ₹242.7
- 50 Day
- ₹234.39
- 100 Day
- ₹216.29
- 200 Day
- ₹207.09
Sun Pharma Advanced Research Company Resistance and Support
Resistance | |
---|---|
First Resistance | ₹226 |
Second Resistance | ₹229.35 |
Third Resistance | ₹231.35 |
RSI | 38.37 |
MFI | 59.08 |
MACD Single Line | 2.27 |
MACD | -1.47 |
Support | |
---|---|
First Resistance | ₹220.65 |
Second Resistance | ₹218.65 |
Third Resistance | ₹215.3 |
Sun Pharma Advanced Research Company Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 285,977 | 10,146,464 | 35.48 |
Week | 297,897 | 10,786,859 | 36.21 |
1 Month | 2,028,175 | 38,717,868 | 19.09 |
6 Month | 1,087,232 | 25,028,078 | 23.02 |
Sun Pharma Advanced Research Company Result Highlights
Sun Pharma Advanced Research Company Synopsis
NSE-Medical-Biomed/Biotech
Sun Pharma Advanced is involved in the business activities of Scientific research and development. Company’s Total Operating Revenue is Rs. 238.78 Cr. and Equity Capital is Rs. 32.45 Cr. for the Year ended 31/03/2023. Sun Pharma Advanced Research Company Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L73100GJ2006PLC047837 and registration number is 047837.Market Cap | 7,287 |
Sales | 234 |
Shares in Float | 11.03 |
No of funds | 82 |
Yield |
Book Value | 14.09 |
U/D Vol ratio | 3.1 |
LTDebt / Equity | |
Alpha | 0.03 |
Beta | 0.71 |
Sun Pharma Advanced Research Company
Owner Name | Jun-23 | Mar-23 | Jan-23 | Dec-22 |
---|---|---|---|---|
Promoters | 65.67% | 65.67% | 65.67% | 68.22% |
Mutual Funds | 0.21% | 0.21% | 0.21% | 0.25% |
Foreign Portfolio Investors | 3.64% | 3.64% | 3.54% | 3.48% |
Financial Institutions/ Banks | ||||
Individual Investors | 16.13% | 16.18% | 16.34% | 16% |
Others | 14.35% | 14.3% | 14.24% | 12.05% |
Sun Pharma Advanced Research Company Management
Name | Designation |
---|---|
Mr. Dilip S Shanghvi | Chairman & Non-Exe.Director |
Dr. T Rajamannar | Non Executive Director |
Dr. Robert J Spiegel | Independent Director |
Mr. Sudhir V Valia | Non Executive Director |
Ms. Bhavna Doshi | Independent Director |
Dr. Ferzaan Engineer | Independent Director |
Sun Pharma Advanced Research Company Forecast
Price Estimates
Sun Pharma Advanced Research Company Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-08-07 | Quarterly Results | |
2023-05-22 | Audited Results & Others | To consider Fund Raising |
2023-02-13 | Quarterly Results | |
2022-11-07 | Quarterly Results | |
2022-08-08 | Quarterly Results & Others | Inter alia, to consider and evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals. |
- Company Name
- CMP
- Chg(%)
- Eicher Motors
- 3475
- 2.6
- Nestle India
- 23025
- 1.7
- Hero Motocorp
- 3022
- 1.6
- Bajaj Auto
- 5079
- 1.5
- Tata Steel
- 129
- 1.5
- Company Name
- CMP
- Chg(%)
- IndusInd Bank
- 1420
- -1.6
- Tech Mahindra
- 1283
- -1.3
- Cipla
- 1165
- -1.2
- Kotak Mah. Bank
- 1766
- -1.0
- Bajaj Finserv
- 1562
- -1.0
Sun Pharma Advanced Research Company FAQs
What is Share Price of Sun Pharma Advanced Research Company ?
Sun Pharma Advanced Research Company share price is ₹224 As on 26 September, 2023 | 14:40
What is the Market Cap of Sun Pharma Advanced Research Company ?
The Market Cap of Sun Pharma Advanced Research Company is ₹7296.9 Cr As on 26 September, 2023 | 14:40
What is the P/E ratio of Sun Pharma Advanced Research Company ?
The P/E ratio of Sun Pharma Advanced Research Company is -31 As on 26 September, 2023 | 14:40
What is the PB ratio of Sun Pharma Advanced Research Company ?
The PB ratio of Sun Pharma Advanced Research Company is 14.2 As on 26 September, 2023 | 14:40